Key terms

About CATX

Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1998 and is headquartered in Seattle, WA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CATX news

Apr 01 7:53am ET Perspective Therapeutics price target raised to $1.50 from $1.20 at Oppenheimer Mar 28 7:33am ET Perspective Therapeutics sees cash runway into 2026 Mar 28 7:33am ET Perspective Therapeutics reports 2023 EPS (17c) vs. (8c) last year Mar 27 12:30pm ET Analysts Are Bullish on These Healthcare Stocks: 89bio (ETNB), Perspective Therapeutics (CATX) Mar 21 7:27am ET Buy Rating Affirmed for Perspective Therapeutics Amid Clinical Success and Strategic Partnerships Mar 19 8:03am ET Analysts Are Bullish on These Healthcare Stocks: Perspective Therapeutics (CATX), Neurogene (NGNE) Mar 18 9:50am ET Perspective Therapeutics to host analyst day Mar 18 8:15am ET Perspective Therapeutics announces collaboration agreement with Bristol Myers Mar 18 4:55am ET Perspective Therapeutics to host analyst day Mar 18 4:55am ET Perspective Therapeutics to host analyst day Mar 17 2:38pm ET Perspective Therapeutics to host analyst day Mar 12 7:40am ET 5 Stocks Corporate Insiders are Buying in March 2024 Mar 11 3:35pm ET Fly Insider : Echostar, Dell among week’s notable insider trades Mar 06 7:50am ET Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX) and Perspective Therapeutics (CATX) Mar 05 8:15am ET Perspective Therapeutics acquires CGMP-compliant manufacturing facility Mar 04 10:00am ET Perspective Therapeutics Inc trading resumes Mar 04 9:46am ET Perspective Therapeutics sells 92M shares at 95c in private placement Mar 04 9:29am ET Perspective Therapeutics Inc trading halted, news pending Feb 06 4:59am ET Perspective Therapeutics Updates Corporate Presentation Online Feb 05 3:56pm ET Fly Insider: Skye Bioscience, Coinbase among week’s notable insider trades Feb 01 8:10am ET Perspective introduces ‘pre-targeting’ Theranostic Technology Platform Jan 29 3:48pm ET Fly Insider: Edgewise, Arch Resources among week’s notable insider trades Jan 29 3:48pm ET Fly Insider: Edgewise,Arch Resources among week’s notable insider trades Jan 26 8:13am ET Perspective Therapeutics initiated with a Buy at B. Riley Jan 22 2:47pm ET Oppenheimer Remains a Buy on Perspective Therapeutics (CATX) Jan 18 8:16am ET Perspective Therapeutics 132.08M share Spot Secondary priced at $0.37 Jan 18 7:06am ET Perspective Therapeutics prices 132.08M shares at 37c in public offering Jan 17 4:08pm ET Perspective Therapeutics announces common stock, warrants offering Jan 17 8:06am ET Perspective Therapeutics begins recruitment of second dosing cohorts Jan 09 8:19am ET Perspective Therapeutics enters strategic agreements with Lantheus Jan 09 8:10am ET Lantheus expands radiopharmaceutical oncology pipeline via agreements

No recent news articles are available for CATX

No recent press releases are available for CATX

CATX Financials

1-year income & revenue

Key terms

CATX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CATX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms